Rheumatology therapy is one of the fastest-growing segments of the Indian pharmaceutical market, driven by the rising cases of arthritis, joint disorders, autoimmune diseases, and chronic inflammation. Cafoli, a trusted and innovation-driven pharmaceutical company, offers a powerful opportunity to healthcare distributors, medical professionals, and entrepreneurs through its Rheumatology Therapy PCD Pharma Franchise program.
Cafoli provides a wide range of advanced formulations tailored for conditions such as rheumatoid arthritis, osteoarthritis, gout, ankylosing spondylitis, and musculoskeletal disorders. Our product line includes NSAIDs, corticosteroids, DMARDs, analgesics, muscle relaxants, and combination therapies formulated under strict WHO-GMP standards. This ensures maximum safety, efficacy, and long-term patient benefits.